Iloperidone
Back to searchMolecule Structure
Scientific Name
Iloperidone
Description of the Drug
Iloperidone is an atypical antipsychotic agent used for the acute treatment of schizophrenia in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04946
http://www.drugbank.ca/drugs/DB04946
Brand Name(s)
Fanapt, Iloperidone
Company Owner(s)
Lupin Ltd, Vanda Pharmaceuticals Inc, Inventia Healthcare Ltd, Taro Pharmaceutical Industries Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL115755 | |
Human Metabolome Database | HMDB0253402 | |
DrugBank | DB04946 | |
PubChem: Thomson Pharma | 14905142 | |
PubChem | 71360 | |
Mcule | MCULE-1792333504 | |
LINCS | LSM-5598 | |
Nikkaji | J550.684K | |
BindingDB | 50034043 | |
EPA CompTox Dashboard | DTXSID6049060 | |
DrugCentral | 3294 | |
ChemicalBook | CB4772066 | |
Guide to Pharmacology | 87 | |
rxnorm | FANAPT | ILOPERIDONE |
PubChem: Drugs of the Future | 12014542 | |
ChEBI | 65173 | |
ZINC | ZINC000001548097 |